The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Agasarov L.G.

I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)

Aphanova T.V.

National Medical Research Center for Rehabilitation and Balneology

Sergeev V.N.

National Medical Research Center for Rehabilitation and Balneology

Fesyun A.D.

National Medical Research Centre for Rehabilitation and Balneology

Krukova M.M.

National Medical Research Center of Rehabilitation and Balneology

Vasilyeva V.A.

National Medical Research Center of Rehabilitation and Balneology

Kulchitskaya D.B.

National Medical Research Center for Rehabilitation and Balneology

Konchugova T.V.

National Medical Research Center for Rehabilitation and Balneology

Puzyreva G.A.

National Medical Research Center of Rehabilitation and Balneology

Yakovlev M.Yu.

National Medical Research Center for Rehabilitation and Balneology

Nutraceutical correction in the complex non-drug treatment of metabolic syndrome

Authors:

Agasarov L.G., Aphanova T.V., Sergeev V.N., Fesyun A.D., Krukova M.M., Vasilyeva V.A., Kulchitskaya D.B., Konchugova T.V., Puzyreva G.A., Yakovlev M.Yu.

More about the authors

Read: 5746 times


To cite this article:

Agasarov LG, Aphanova TV, Sergeev VN, et al. . Nutraceutical correction in the complex non-drug treatment of metabolic syndrome. Problems of Balneology, Physiotherapy and Exercise Therapy. 2021;98(4):25‑31. (In Russ.)
https://doi.org/10.17116/kurort20219804125

Recommended articles:
Rela­tionship between meta­bolic syndrome components and pathology of the red border of the lips and oral mucosa. Russian Journal of Operative Surgery and Clinical Anatomy. 2024;(4-2):58-63
Pote­ntial for the use of nutraceuticals for hype­rlipidemia correction. Russian Journal of Preventive Medi­cine. 2025;(3):40-45
Short-chain fatty acid profile in patients unde­rgoing maintenance hemo­dialysis. Russian Journal of Evidence-Based Gastroenterology. 2025;(1):47-54
Modern aspe­cts of functional hypo­thalamic amenorrhea. Russian Bulletin of Obstetrician-Gynecologist. 2025;(2):55-60

References:

  1. Wirth A, Wabitsch M, Hauner H. The prevention and treatment of obesity. Dtsch Arztebl Int. 2014;111(42):705-713.  https://doi.org/10.3238/arztebl.2014.0705
  2. Bastien M, Poirier P, Lemieux I, Després JP. Overview of epidemiology and contribution of obesity to cardiovascular disease. Prog Cardiovasc Dis. 2014;56:369-381. 
  3. American College of Cardiology/American Heart Association Task Force on Practice Guidelines, Obesity Expert Panel, 2013. Expert Panel Report: Guidelines (2013) for the management of overweight and obesity in adults. Obesity (Silver Spring). 2014;22(suppl 2):41-410.  https://doi.org/10.1002/oby.20660
  4. Roberts CK, Hevener AL, Barnard RJ. Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training. Comprehensive Physiology. 2013;3(1):1-58.  https://doi.org/10.1002/cphy.c110062
  5. Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M, Sanyal AJ. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012;55(6):2005-2023. https://doi.org/10.1002/hep.25762
  6. Fabbrini E, Sullivan S, Klein S. Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology. 2010;51(2):679-689.  https://doi.org/10.1002/hep.23280
  7. Wijarnpreecha K, Aby ES, Ahmed A, Kim D. Evaluation and Management of Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease. Clin Mol Hepatol. 2021;27(2):221-235.  https://doi.org/10.3350/cmh.2020.0239
  8. Ascher S, Reinhardt C. The gut microbiota: An emerging risk factor for cardiovascular and cerebrovascular disease. Eur J Immunol. 2018;48(4):564-575.  https://doi.org/10.1002/eji.201646879
  9. Torbahn G, Schoene D, Schwingshackl L, Rücker G, Knüttel H, Kemmler W, Sieber CC, Batsis JA, Villareal DT, Stroebele-Benschop N, Volkert D, Kiesswetter E. Effective SLOPE: EffectS of Lifestyle interventions in Older PEople with obesity: a systematic review and network meta-analysis protocol. BMJ Open. 2020;10(10):e038330. https://doi.org/10.1136/bmjopen-2020-038330
  10. Chasova IE. Recommendations for the management of patients with metabolic syndrome. Clinical guidelines. M. 2013. (In Russ.).
  11. Donini LM, Pinto A, Giusti AM, Lenzi A, Poggiogalle E. Obesity or BMI Paradox? Beneath the Tip of the Iceberg. Front Nutr. 2020;7:53.  https://doi.org/10.3389/fnut.2020.00053
  12. Lin TY, Lim PS, Hung SC. Impact of misclassification of obesity by body mass index on mortality in patients with CKD. Kidney Int Rep. 2017;3:447-455.  https://doi.org/10.1016/j.ekir.2017.12.009
  13. Coutinho T, Goel K, Corrêa de Sá D, Kragelund C, Kanaya AM, Zeller M, et al. Central obesity and survival in subjects with coronary artery disease: a systematic review of the literature and collaborative analysis with individual subject data. J Am Coll Cardiol. 2011;57:1877-1886. https://doi.org/10.1016/j.jacc.2010.11.058
  14. Lu Q. Personalized nutrition and obesity. Annals of medicine. 2014;46(5):247-252.  https://doi.org/10.3109/07853890.2014.891802
  15. Di Baise JK, Zhang H, Crowell MD, Krajmalnik-Brown R, Decker GA, Rittmann BE. Gut microbiota and its relationship with obesity. Mayo Clin Proc. 2008;83(4):460-469. 
  16. Chihacheva EA, Seliverstov PV, Erofeev NP, Dobrica VP, Radchenko VG. Improving the effectiveness of therapy in patients with liver disease associated with intestinal dysbiosis with short-chain fatty acids. Lechashchij vrach. 2013;1:85-91. (In Russ.).
  17. Yee JK, Phillips SA, Allamehzadeh K, Herbst KL. Subcutaneous adipose tissue fatty acid desaturation in adults with and without rare adipose disorders. Lipids Health Dis. 2012;11(19):1-11.  https://doi.org/10.1186/1476-511X-11-19
  18. Marcks N, Aimo A, Januzzi JL Jr, Vergaro G, Clerico A, Latini R, Meessen J, Anand IS, Cohn JN, Gravning J, Ueland T, Bayes-Genis A, Lupón J, de Boer RA, Yoshihisa A, Takeishi Y, Egstrup M, Gustafsson I, Gaggin HK, Eggers KM, Huber K, Tentzeris I, Ripoli A, Passino C, Sanders-van Wijk S, Emdin M, Brunner-La Rocca HP. Re-appraisal of the obesity paradox in heart failure: a meta-analysis of individual data. Clin Res Cardiol. 2021 Mar 11. Epub ahead of print. https://doi.org/10.1007/s00392-021-01822-1
  19. Johansson K, Neovius M, Hemmingsson E. Effects of anti-obesity drugs, diet, and exercise on weight-loss maintenance after a very-low-calorie diet or low-calorie diet: a systematic review and meta-analysis of randomized controlled trials. Am J Clin Nutr. 2014;99(1):14-23.  https://doi.org/10.3945/ajcn.113.070052

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.